WASHINGTON (AP) -- The makers of a breakthrough drug for hepatitis C put profits before patients in pricing the $1,000 pill that cures the liver-wasting disease, Senate investigators said Tuesday....
By RICARDO ALONSO-ZALDIVAR, Associated Press: Business
Tue, 12/01/2015 - 10:32am
WASHINGTON (AP) -- The makers of a breakthrough drug for hepatitis C put profits before patients in pricing the $1,000 pill that cures the liver-wasting disease, Senate investigators said Tuesday....